Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 49
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Low cost snake antivenom for Asia, Africa and South America

    Death by snake venom in India, Africa, and South America are substantial. Traditional antidotes are prohibitively...

    Using Gene Therapy to Target and Treat Cancers

    Non-coding RNAs regulate levels of gene expression in cells, meaning that we now have a unique tool that...

    Backer Badge Funded